FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Gregory Masters

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Physiology

Drug Tolerance

Co-author Network

Publications

TOP 3
Charles Rudin; Ravi Salgia; Xiaofei Wang; Lydia D Hodgson; Gregory A Masters; Mark Green; Everett E Vokes
Randomized phase II Study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer: CALGB 30103.
Martin J Edelman; Dee Watson; Xiaofei Wang; Carl Morrison; Robert A Kratzke; Scott Jewell; Lydia Hodgson; Ann M Mauer; Ajeet Gajra; Gregory A Masters; Michelle Bedor; Everett E Vokes; Mark J Green
Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203.
Johnny Kao; Suzanne D Conzen; Nora T Jaskowiak; DAVID SONG; Wendy Recant; Rachana Singh; Gregory A Masters; Gini F Fleming; Ruth Heimann
Concomitant radiation therapy and paclitaxel for unresectable locally advanced breast cancer: results from two consecutive phase I/II trials.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Gregory Masters (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Charles Rudin; Ravi Salgia; Xiaofei Wang; Lydia D Hodgson; Gregory A Masters; Mark Green; Everett E Vokes
Randomized phase II Study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer: CALGB 30103.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(6):870-6.
2008: Martin J Edelman; Dee Watson; Xiaofei Wang; Carl Morrison; Robert A Kratzke; Scott Jewell; Lydia Hodgson; Ann M Mauer; Ajeet Gajra; Gregory A Masters; Michelle Bedor; Everett E Vokes; Mark J Green
Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(6):848-55.
2005: Johnny Kao; Suzanne D Conzen; Nora T Jaskowiak; DAVID SONG; Wendy Recant; Rachana Singh; Gregory A Masters; Gini F Fleming; Ruth Heimann
Concomitant radiation therapy and paclitaxel for unresectable locally advanced breast cancer: results from two consecutive phase I/II trials.
International journal of radiation oncology, biology, physics 2005;61(4):1045-53.
2002: Philip C Hoffman; Ezra E W Cohen; Gregory A Masters; Daniel J Haraf; Ann M Mauer; Charles Rudin; Stuart A Krauss; Dezheng Huo; Everett E Vokes
Carboplatin plus vinorelbine with concomitant radiation therapy in advanced non-small cell lung cancer: a phase I study.
Lung cancer (Amsterdam, Netherlands) 2002;38(1):65-71.
2000: Mark K Ferguson; J Wang; Philip C Hoffman; Daniel J Haraf; J Olak; Gregory A Masters; Everett E Vokes
Sex-associated differences in survival of patients undergoing resection for lung cancer.
The Annals of thoracic surgery 2000;69(1):245-9; discussion 249-50.
1998: Everett E Vokes; Rafat H Ansari; Gregory A Masters; Philip C Hoffman; A Klepsch; Mark J Ratain; David F Sciortino; T E Lad; Stuart Krauss; Paul A. Fishkin; HM Golomb
A phase II study of 9-aminocamptothecin in advanced non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(10):1085-90.
1998: Gregory A Masters; Ann M Mauer; Philip C Hoffman; D Wyka; Brian L Samuels; Stuart A Krauss; Sylvia Watson; HM Golomb; Everett E Vokes
A phase I-II study of paclitaxel, ifosfamide, and vinorelbine with filgrastim (rhG-CSF) support in advanced non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(6):677-80.
1998: Gregory A Masters; Daniel J Haraf; Philip C Hoffman; LC Drinkard; Stuart A Krauss; Mark K Ferguson; J Olak; Brian L Samuels; HM Golomb; Everett E Vokes
Phase I study of vinorelbine, cisplatin, and concomitant thoracic radiation in the treatment of advanced chest malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(6):2157-63.
1998: Everett E Vokes; Gregory A Masters; Ann M Mauer; Philip C Hoffman; Sylvia Watson; HM Golomb
Ifosfamide-based three-drug combination regimens in non-small cell lung cancer.
Seminars in oncology 1998;25(1 Suppl 2):19-22.
1998: Gregory A Masters; Philip C Hoffman; LC Drinkard; Brian L Samuels; HM Golomb; Everett E Vokes
A review of ifosfamide and vinorelbine in advanced non-small cell carcinoma of the lung.
Seminars in oncology 1998;25(1 Suppl 2):8-14.
1998: Ann M Mauer; Gregory A Masters; Daniel J Haraf; Philip C Hoffman; S M Watson; HM Golomb; Everett E Vokes
Phase I study of docetaxel with concomitant thoracic radiation therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(1):159-64.
1997: Everett E Vokes; Gregory A Masters; Ann M Mauer; Daniel J Haraf; Philip C Hoffman; HM Golomb
Clinical studies of docetaxel (Taxotere) and concomitant chest therapy.
Seminars in oncology 1997;24(4 Suppl 14):S14-26-S14-29.
1997: Everett E Vokes; Ann M Mauer; Philip C Hoffman; Gregory A Masters; Sylvia Watson; HM Golomb
Paclitaxel/carboplatin plus ifosfamide in non-small cell lung cancer.
Seminars in oncology 1997;24(4 Suppl 12):S12-67-S12-69.
1997: Gregory A Masters; Philip C Hoffman; A Hsieh; LC Drinkard; R Mick; Brian L Samuels; A Guaspari; HM Golomb; Everett E Vokes
Phase I study of vinorelbine and ifosfamide in advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(3):884-92.
1996: Everett E Vokes; Philip C Hoffman; Gregory A Masters; HM Golomb; LC Drinkard; Stuart A Krauss
Ifosfamide-based chemotherapy for non-small cell lung cancer: phase I/II studies at the University of Chicago.
Seminars in oncology 1996;23(3 Suppl 7):15-8.
1996: Philip C Hoffman; Gregory A Masters; LC Drinkard; Stuart A Krauss; Brian L Samuels; HM Golomb; Everett E Vokes
Ifosfamide-based combination chemotherapy in advanced non-small cell lung cancer: two phase I studies.
Seminars in oncology 1996;23(3 Suppl 6):11-5.
1996: Everett E Vokes; Daniel J Haraf; Gregory A Masters; Philip C Hoffman; LC Drinkard; M Ferguson; J Olak; Sylvia Watson; HM Golomb
Vinorelbine (Navelbine), cisplatin, and concomitant radiation therapy for advanced malignancies of the chest: a Phase I study.
Seminars in oncology 1996;23(2 Suppl 5):48-52.
1996: Gregory A Masters; Philip C Hoffman; LC Drinkard; Sylvia Watson; Brian L Samuels; HM Golomb; Everett E Vokes
Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
Seminars in oncology 1996;23(2 Suppl 5):11-8.
1996: Philip C Hoffman; Gregory A Masters; LC Drinkard; Stuart A Krauss; Brian L Samuels; HM Golomb; Everett E Vokes
Ifosfamide plus paclitaxel in advanced non-small-cell lung cancer: a phase I study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(3):314-6.
1995: Gregory A Masters; LC Drinkard; Philip C Hoffman; N Lane; Sylvia Watson; Brian L Samuels; Jacob Bitran; HM Golomb; Everett E Vokes
A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
The cancer journal from Scientific American 1995;1(4):288-94.
1995: Philip C Hoffman; Stuart A Krauss; LC Drinkard; Gregory A Masters; Brian L Samuels; Jacob Bitran; HM Golomb; Sylvia Watson; Everett E Vokes
Paclitaxel and ifosfamide: a multicenter phase I study in advanced non-small cell lung cancer.
Seminars in oncology 1995;22(4 Suppl 9):38-41.
1995: Gregory A Masters; HM Golomb
Management of pulmonary metastases.
Lancet 1995;346(8967):68.